3/29/2018
Nitesh Sangral
Early Times Report
Jammu, Mar 29: Ignoring J&K High Court's directions
to purchase Factor VIII (FVIII) at lowest rates, the Government Medical College
and Hospital Jammu and associated hospitals made purchases at exorbitant rates.
The HC's order copy in possession of Early Times states
that on March 23, 2018, Judge Alok Aradhe disposed of writ petition filed by
Advocate Ankur Sharma, by directing the respondent to procure the drugs for
haemophilia patients before March 31, 2018 from competitive available lowest
suppliers.
FVIII is an essential blood-clotting protein, also
known as anti-hemophilic factor (AHF).
If official sources are to be believed, the hospital
authorities made purchases from a company allegedly under the influence of some
doctors who are not willing to administer drugs of other companies to patients.
It exposes the alleged nexus of some doctors with pharmaceutical companies.
Earlier, some senior doctors, seeking anonymity, said
that the purchase committee had decided to buy the purchase factor before March
31, 2018. But some doctors were not ready to buy the factors from the suppliers
with lowest rates, following which a writ petition was filed in court. The
court asked concern authorities to the drug as soon as possible at lowest rates
available.
Principal of GMCH Jammu Dr Sunanda Raina had sought
permission from Director Finance to purchase the drug on the pattern of GMC
Srinagar. The permission was granted. But without checking whether lowest rates
were available, the purchases were made, causing loss to the exchequer.
"Despite availability of lowest rates, the
purchase committee followed footsteps of GMC Srinagar and made purchase to
allegedly benefit some doctors of the hospital," sources said.
Advocate Ankur Sharma said a contempt plea has been
filed in the court against Medical Superintendent of the SMGS hospital for
disobeying the court directions. The supplier who had given lowest rates has also filed
a writ petition in the court.
Comments
Post a Comment